天域生物
(603717)
| 流通市值：18.05亿 | | | 总市值：18.05亿 |
| 流通股本：2.90亿 | | | 总股本：2.90亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 624,472,530.5 | 423,381,788.06 | 211,157,093.9 | 670,454,363.38 |
| 营业收入 | 624,472,530.5 | 423,381,788.06 | 211,157,093.9 | 670,454,363.38 |
| 二、营业总成本 | 594,720,864.52 | 414,460,678.23 | 201,684,498.85 | 1,031,425,073.63 |
| 营业成本 | 501,189,408.91 | 360,172,864.67 | 174,097,406.42 | 901,209,132.02 |
| 税金及附加 | 1,219,476.68 | 857,083.44 | 500,517.11 | 1,352,637.11 |
| 销售费用 | 2,854,511.23 | 2,001,667.61 | 551,232.74 | 2,986,858.55 |
| 管理费用 | 73,712,418.87 | 49,757,802.04 | 21,075,489.78 | 92,424,293.73 |
| 研发费用 | 6,607,811.49 | 3,459,770.68 | 1,624,358.5 | 13,907,987.27 |
| 财务费用 | 9,137,237.34 | -1,788,510.21 | 3,835,494.3 | 19,544,164.95 |
| 其中:利息费用 | 25,342,543.25 | 23,525,135.05 | 8,079,277.61 | 30,557,252.55 |
| 其中:利息收入 | 19,044,788.9 | 25,793,452.09 | 4,284,977.98 | 11,672,325.57 |
| 加:公允价值变动收益 | -82,458.54 | 177,760 | -298,353.84 | 3,190,880 |
| 加:投资收益 | 487,708.97 | 383,003.51 | 595,338.53 | -39,279,843.83 |
| 资产处置收益 | -469,532.31 | -656,694.11 | 57,415.31 | 991,736.89 |
| 资产减值损失(新) | 7,322,808.98 | 8,682,139.53 | 7,125,718.21 | -165,475,728.73 |
| 信用减值损失(新) | -12,106,516.72 | -7,165,855.02 | 3,033,363.43 | -11,423,582.2 |
| 其他收益 | 683,392.04 | 529,174.5 | 244,510.32 | 3,543,435.48 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 25,587,068.4 | 10,870,638.24 | 20,230,587.01 | -569,423,812.64 |
| 加:营业外收入 | 7,370,164.14 | 7,151,905.73 | 2,281,958.32 | 6,678,574.03 |
| 减:营业外支出 | 5,771,417.83 | 3,277,811.89 | 1,766,428 | 15,836,827.64 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 27,185,814.71 | 14,744,732.08 | 20,746,117.33 | -578,582,066.25 |
| 减:所得税费用 | -95,316.9 | 1,043,528.27 | 2,225,495.82 | -12,694,507.9 |
| 六、净利润 | 27,281,131.61 | 13,701,203.81 | 18,520,621.51 | -565,887,558.35 |
| 持续经营净利润 | 27,281,131.61 | 13,701,203.81 | 18,520,621.51 | -565,887,558.35 |
| 归属于母公司股东的净利润 | 6,387,662.07 | 6,228,578.44 | 9,028,099.06 | -461,636,824.63 |
| 少数股东损益 | 20,893,469.54 | 7,472,625.37 | 9,492,522.45 | -104,250,733.72 |
| (一)基本每股收益 | 0.02 | 0.02 | 0.03 | -1.59 |
| (二)稀释每股收益 | 0.02 | 0.02 | 0.03 | -1.59 |
| 九、综合收益总额 | 27,281,131.61 | 13,701,203.81 | 18,520,621.51 | -565,887,558.35 |
| 归属于母公司股东的综合收益总额 | 6,387,662.07 | 6,228,578.44 | 9,028,099.06 | -461,636,824.63 |
| 归属于少数股东的综合收益总额 | 20,893,469.54 | 7,472,625.37 | 9,492,522.45 | -104,250,733.72 |
| 公告日期 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 标准无保留意见 |